|
| 1. | ||
T. Seifen (1), L. Rettenbacher (1), C. Thaler (2), J. Holzmannhofer (1), M. Mc Coy (3), C. Pirich (1) (1) Department of Nuclear Medicine and Endocrinology, University Hospital of Salzburg, Austria; (2) Department of Orthopaedics, University Hospital of Salzburg, Austria; (3) Department of Radiology, Christian-Doppler-Clinic, University Hospital of Salzburg, Austria Nuklearmedizin 2012 51: - http://dx.doi.org/10.3413/Nukmed-0473-12-01 | ||
| [Zusammenfassung] [PDF] [Pay per view] | ||
|
| 1. | ||
I. Letovanec (1), G. Allenbach (2), A. Mihaescu (1), M. Nicod Lalonde (2), S. Schmidt (3), R. Stupp (4), J.-W. Fitting (5), A. Boubaker (2), H.-B. Ris (6), J. O. Prior (2) (1) University Institute of Pathology, Lausanne University Hospital, Switzerland; (2) Department of Nuclear Medicine, Lausanne University Hospital, Switzerland; (3) Department of Radiology, Lausanne University Hospital, Switzerland; (4) Department of Oncology, Lausanne University Hospital, Switzerland; (5) Department of Pneumology, Lausanne University Hospital, Switzerland; (6) Department of Thoracic Surgery, Lausanne University Hospital, Switzerland Nuklearmedizin 2012 51: - http://dx.doi.org/10.3413/Nukmed-0470-12-01 | ||
| [Zusammenfassung] [PDF] [Pay per view] | ||
|
| 1. | ||
D. Viertl (1), F. Perillo-Adamer (2), P. A. André (1), S. M. Ametamey (3), T. L. Ross (3), M. Kosinski (1), Y. M. Dupertuis (4), A. Bischof Delaloye (1), F. Buchegger (5, 1) (1) Department of Nuclear Medicine, University Hospital of Lausanne, Switzerland; (2) Department of Radio-Oncology, University Hospital of Lausanne, Switzerland; (3) Center for Radiopharmaceutical Science, Swiss Federal Institute of Technology of Zurich, Switzerland; (4) Unit of Nutrition, University Hospital of Geneva, Switzerland; (5) Department of Nuclear Medicine, University Hospital of Geneva, Switzerland Nuklearmedizin 2012 51: - http://dx.doi.org/10.3413/Nukmed-0459-12-01 | ||
| [Zusammenfassung] [PDF] [Pay per view] | ||
|
| 1. | ||
J. Nagarajah (1), J. Farahati (2), R. Görges (1), F. Grabellus (3), A. Bockisch (1), S.-Y. Sheu-Grabellus (3) (1) Clinic for Nuclear Medicine, University Hospital of Essen, University of Duisburg-Essen, Germany; (2) Nuclear Medicine Practice, Bottrop, Germany; (3) Institute of Pathology and Neuropathology, University Hospital of Essen, University of Duisburg-Essen, Germany Nuklearmedizin 2012 51: - http://dx.doi.org/10.3413/Nukmed-0472-12-01 | ||
| [Zusammenfassung] [PDF] [Pay per view] | ||
|
| 1. | ||
S. J. Rosenbaum-Krumme (1), A. Bockisch (1), J. Nagarajah (1) (1) Department of Nuclear Medicine, University Hospital Essen, Germany Nuklearmedizin 2012 51: - http://dx.doi.org/10.3413/Nukmed-0474-12-01 | ||
| [Zusammenfassung] [PDF] [Pay per view] | ||
|
| 1. | ||
D. Kahraman (1), C. Eggers (2), A. Holstein (1), C. Schneider (1), D. J. Pedrosa (2), M. Dietlein (1), C. Kobe (1), L. Timmermann (2), M. Schmidt (1) (1) Department of Nuclear Medicine, University Hospital of Cologne, Germany; (2) Department of Neurology, University Hospital of Cologne, Germany Nuklearmedizin 2012 51: - http://dx.doi.org/10.3413/Nukmed-0449-11-12 | ||
| [Zusammenfassung] [PDF] [Pay per view] | ||
|
| 1. | Malignitätsrisiko bei follikulärer Neoplasie Der prädiktive Wert des TSH | |
M. Zimny (1), I. Selkinski (2), S. Blasius (3), T. Rink (1), H.-J. Schroth (1), F. Grünwald (2) (1) Department of Nuclear Medicine, Klinikum Hanau, Germany; (2) Department of Nuclear Medicine, University Hospital Frankfurt am Main, Germany; (3) Department of Pathology, Klinikum Hanau, Germany Nuklearmedizin 2012 51: - http://dx.doi.org/10.3413/Nukmed-0456-12-01 | ||
| [Zusammenfassung] [PDF] [Pay per view] | ||
| 2. | ||
V. Hartung-Knemeyer (1), S. Müller (1), J. Nagarajah (1), H. Lahner (2), M. Broecker-Preuss (3), A. Bockisch (1), R. Görges (1) (1) Klinik für Nuklearmedizin, Universitätsklinikum Essen; (2) Klinik für Endokrinologie, Universitätsklinikum Essen; (3) Zentrallabor Bereich Forschung, Klinik für Endokrinologie und Stoffwechselerkrankungen, Universitätsklinikum Essen Nuklearmedizin 2012 51: - http://dx.doi.org/10.3413/Nukmed-0454-11-12 | ||
| [Zusammenfassung] [PDF] [Pay per view] | ||
| 3. | ||
G. Wunderlich (1), M. Wendisch (1), D. Aurich (1), R. Runge (1), R. Freudenberg (1), J. Kotzerke (1) (1) Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Germany Nuklearmedizin 2012 51: - http://dx.doi.org/10.3413/Nukmed-0450-11-12 | ||
| [Zusammenfassung] [PDF] [Pay per view] | ||
|
| 1. | ||
D. Thorwarth (1), T. Beyer (2, 3), R. Boellaard (4), D. de Ruysscher (5), A. Grgic (6), J. A. Lee (7), U. Pietrzyk (8, 9), B. Sattler (10), A. Schaefer (6), W. van Elmpt (5), W. Vogel (11), W. J. G. Oyen (12), U. Nestle (13) (1) University Hospital for Radiation Oncology, Section for Biomedical Physics, Eberhard-Karls University Tübingen, Germany; (2) University Hospital for Radiology, Imaging Science Institute Tübingen, Germany; (3) cmi-experts, Zürich, Switzerland; (4) University Medical Centre, Department of Nuclear Medicine & PET Research, Amsterdam, The Netherlands; (5) Department of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands; (6) Department of Nuclear Medicine, Saarland University Medical Center, Homburg/Saar, Germany; (7) Center of Molecular Imaging and Experimental Radiotherapy, Université Catholique de Louvain, Brussels, Belgium; (8) Institute of Neurosciences and Medicine – Medical Imaging Physics (INM-4), Research Center Jülich, Germany; (9) Faculty of Mathematics and Natural Sciences, University of Wuppertal, Germany; (10) Department of Nuclear Medicine, University Hospital Leipzig, Germany; (11) Departments of Nuclear Medicine and Radiation Oncology, The Netherlands Cancer Institute – Antoni van Leeuwenhoek ziekenhuis (NKI-AVL), Amsterdam; (12) Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, The Netherlands; (13) University Hospital for Radiation Oncology Freiburg, Germany Nuklearmedizin 2012 51: - http://dx.doi.org/10.3413/Nukmed-0455-11-12 | ||
| [Zusammenfassung] [PDF] [Pay per view] | ||
| 2. | ||
H. Wieder (1, 2), L. S. Freudenberg (1, 3), J. Czernin (4), B. N. Navar (5), O. Israel (6), T. Beyer (3, 7) (1) Zentrum für Radiologie und Nuklearmedizin (ZRN), Grevenbroich, Dormagen, Neuss, Germany; (2) Department of Nuclear Medicine, Klinikum rechts der Isar, München, Germany; (3) Department of Nuclear Medicine, University Hospital Essen, Germany; (4) Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; (5) AMI, Los Angeles, CA, USA; (6) Rambam Health Care Campus, Haifa, Israel; (7) cmi-experts GmbH, Zürich, Switzerland Nuklearmedizin 2012 51: - http://dx.doi.org/10.3413/Nukmed-0467-12-01 | ||
| [Zusammenfassung] [PDF] [Pay per view] | ||